For: | Kim KH, Park KK. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol 2014; 20(40): 14696-14705 [PMID: 25356032 DOI: 10.3748/wjg.v20.i40.14696] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14696.htm |
Number | Citing Articles |
1 |
Kira Bettermann. Mechanisms of Molecular Carcinogenesis – Volume 1. 2017; : 87 doi: 10.1007/978-3-319-53659-0_6
|
2 |
Jung-Yeon Kim, Hyun-Jin An, Woon-Hae Kim, Mi-Gyeong Gwon, Hyemin Gu, Yoon-Yub Park, Kwan-Kyu Park. Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis. Molecular Therapy - Nucleic Acids 2017; 8: 250 doi: 10.1016/j.omtn.2017.06.022
|
3 |
Matthias Ocker, Daniel Neureiter. Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation. Expert Opinion on Investigational Drugs 2023; 32(12): 1133 doi: 10.1080/13543784.2023.2288075
|
4 |
Lu Ma, Xude Wang, Wei Li, Fanzhi Qu, Yafei Liu, Jincai Lu, Guangyue Su, Yuqing Zhao. Conjugation of Ginsenoside with Dietary Amino Acids: A Promising Strategy To Suppress Cell Proliferation and Induce Apoptosis in Activated Hepatic Stellate Cells. Journal of Agricultural and Food Chemistry 2019; 67(36): 10245 doi: 10.1021/acs.jafc.9b03305
|
5 |
|
6 |
Rajagopal N. Aravalli, John D. Belcher, Clifford J. Steer. Liver‐targeted gene therapy: Approaches and challenges. Liver Transplantation 2015; 21(6): 718 doi: 10.1002/lt.24122
|
7 |
K.I. Papadopoulos, P. Wattanaarsakit, W. Prasongchean, R. Narain. Polymers and Nanomaterials for Gene Therapy. 2016; : 231 doi: 10.1016/B978-0-08-100520-0.00010-2
|
8 |
Hyun Jin Jung, Hyun-Jin An, Mi-Gyeong Gwon, Hyemin Gu, Seongjae Bae, Sun-Jae Lee, Young-Ah Kim, Jaechan Leem, Kwan-Kyu Park. Anti-Fibrotic Effect of Synthetic Noncoding Oligodeoxynucleotide for Inhibiting mTOR and STAT3 via the Regulation of Autophagy in an Animal Model of Renal Injury. Molecules 2022; 27(3): 766 doi: 10.3390/molecules27030766
|